A detailed history of Exane Derivatives transactions in Signature Bank Corp stock. As of the latest transaction made, Exane Derivatives holds 465 shares of SBNY stock, worth $576. This represents 0.05% of its overall portfolio holdings.

Number of Shares
465
Previous 1,685 72.4%
Holding current value
$576
Previous $494,000 83.2%
% of portfolio
0.05%
Previous 0.15%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$167.55 - $289.82 $204,411 - $353,580
-1,220 Reduced 72.4%
465 $83,000
Q1 2022

Apr 22, 2022

SELL
$277.95 - $366.0 $191,785 - $252,540
-690 Reduced 29.05%
1,685 $494,000
Q4 2021

Jan 28, 2022

BUY
$286.09 - $339.63 $236,882 - $281,213
828 Added 53.52%
2,375 $768,000
Q3 2021

Oct 26, 2021

BUY
$226.83 - $276.64 $82,566 - $100,696
364 Added 30.77%
1,547 $421,000
Q2 2021

Jul 28, 2021

SELL
$219.23 - $258.35 $42,311 - $49,861
-193 Reduced 14.03%
1,183 $290,000
Q1 2021

Apr 30, 2021

BUY
$135.43 - $245.95 $186,351 - $338,427
1,376 New
1,376 $311,000

Others Institutions Holding SBNY

About Signature Bank Corp


  • Ticker SBNY
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Banks—Regional
  • Shares Outstandng 62,929,100
  • Market Cap $78M
  • Description
  • Signature Bank provides commercial banking products and services. It accepts various deposit products, including checking accounts, money market accounts, escrow deposit accounts, cash concentration accounts, certificates of deposit, and other cash management products. The company provides various lending products comprising commercial and indus...
More about SBNY
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.